A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation

AIM: To evaluate the efficacy and safety of tegaserod, 6 mg twice daily (b.i.d.), in men and women with chronic constipation (CC) from China. METHODS: This was a multicenter, double-blind, placebo-controlled study. Following a 2-wk treatment-free baseline period, patients were randomized to receive...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lin, San-Ren, Ke, Mei-Yun, Luo, Jin-Yan, Yuan, Yao-Zong, Wang, Ji-Yao, diTommaso, Shelley, Walter, Verena, Huang, Jiaqing
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2007
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4066006/
https://ncbi.nlm.nih.gov/pubmed/17278196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i5.732
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller